EN DE
Watch Strategic Partners A/S does not have significant operations for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Strategic Partners A/S does not have significant operations (STRAP) fair value: what the stock is really worth

As of Nov 9, 2026: fair value (intrinsic value) of Strategic Partners A/S does not have significant operations stock DKK 403, price DKK 590, that is 31.6% below the price, quality 49 out of 100. Rating: overvalued. The value is an estimate: none of our valuation models currently carries, it draws on revenue and assets compared with similar companies. Updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Healthcare DK · ISIN DK0062502894

SP Strategic Partners A/S does not have significant operations logo Thin data Nov 10, 2026

Strategic Partners A/S does not have significant operations

STRAP · CO
Expensive, weak quality

Our calculation puts a fair price 32% below what the stock costs today.

Generates free cash flow over the last twelve months
Ranks above peers (5/7)
Quality 49/100
Fair value kr 403.38 · Overvalued
Weak Growth
Narrow moat 18/100 · thin data
Thin data
Estimate⚠ Thinly traded
Watch Strategic Partners A/S does not have significant operations for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

kr 100,000 kr 530.00 Fair Value kr 403.38 Jun 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 10, 2026.

How to read this chart

60‑month range kr 530.00 – kr 100,000 · fair‑value band kr 302.53 – kr 504.22 · the kr 590.00 price screens above the kr 403.38 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 10, 2026.

Follow Strategic Partners A/S does not have significant operations in your weekly email

Every Wednesday you see whether Strategic Partners A/S does not have significant operations is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Strategic Partners A/S does not have significant operations. Previously, it was engaged in biotech activities. The company was formerly known as Orphazyme A/S and changed its name to Strategic Partners A/S in October 2024.

Show moreShow less

Strategic Partners A/S was incorporated in 2009 and is based in Herlev, Denmark.

Stock analysis

Strategic Partners A/S does not have significant operations (STRAP) currently trades at kr 590.00, while our estimate is kr 403.38, 32% below the price, so the stock looks overvalued today.

Show more

Valuation

None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.

Scenario range: kr 302.53 (bear) to kr 504.22 (bull), the price of kr 590.00 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 49/100 (below-average quality), in the Healthcare sector.

Weak Growth: Revenue growth is weak, negative or inconsistent.

Strategic Partners A/S does not have significant operations reported revenue of 309K DKK in FY2025 versus 0 DKK in FY2020. Reported net income was −859K DKK in FY2025.

Key figures

Market cap 32.7M DKK (≈ $4.9M) Micro · P/E ratio 20.1 · EPS (TTM) kr 29.33 · Return on equity 7.2% · Return on assets (EBIT) −54.8% (5-year average) · Operating margin −927% · Revenue (TTM) 304K DKK · Revenue growth (YoY) −4.8%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 18 out of 100 (low confidence).

What moves the price

The share trades about 33% below its 52-week high and 11% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at −6% fair-value upside, at −32%, STRAP screens richer than that median.

Fair Value

Bear kr 302.53 Fair Value kr 403.38 Bull kr 504.22
Price kr 590.00 · Downside -31.6%
Estimate. None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.

Quality Score breakdown

Overall quality 49/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 1
How much profit the company makes from its sales and capital
Quality Growth 38
Are margins and returns getting better?
Cashflow 50
Do the profits arrive as real cash?
Financial strength 77
Debt, balance sheet and risk of trouble
Investment 100
Does it invest with discipline instead of growing at any price?
Low Volatility 50
How calm the share price moves, does not count
Price momentum 23
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 7
Distance to the 52-week high, does not count
New shares 50
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 10/100
Revenue growth is weak, negative or inconsistent.
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

STRAP screens overvalued: fair value 32% below the price. Compare with Vertex Pharmaceuticals Incorporated →

Compare Strategic Partners A/S does not have significant operations with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Biotechnology · 867 stocks

Beats the industry median on 5/7 measures
Overall it ranks above its industry peers.
Valuation
Quality Score 49 · Above median
Fair Value upside −31.6% · Below median
Profitability
Return on equity (12 months) 7.2% · Top 25%
Return on assets −4.4% · Above median
Growth and dividend
Revenue growth (quarter YoY) −4.8% · Below median

Valuation Multiplesvs Biotechnology median · lower = cheaper

P/E (12 months) 20.1× · Cheaper than median
P/B 1.78× · Cheaper than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 0
FUTURE (revenue growth)0 · sector 0
PAST (return on equity)29 · sector 0
HEALTH (low debt)0 · sector 96
DIVIDEND (yield)0 · sector 19

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Biotechnology stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Regeneron Pharmaceuticals, Inc REGN $919.96 $1,275 +39% vs STRAP
Samsung Biologics Co 207940 1,510,000 KRW 1,661,000 KRW +10% vs STRAP
Vertex Pharmaceuticals Incorporated VRTX $550.87 $601.80 +9% vs STRAP
Genmab A/S GMAB kr 3,661 kr 3,880 +6% vs STRAP
argenx SE ARGX $962.27 $908.40 −6% vs STRAP
CSL Limited CSL A$200.73 A$181.40 −10% vs STRAP
BeOne Medicines AG 6160 HK$248.20 HK$152.80 −38% vs STRAP
Roivant Sciences Ltd ROIV $40.67 $17.39 −57% vs STRAP
Celltrion, Inc 068270 210,000 KRW 74,945 KRW −64% vs STRAP
Royalty Pharma plc RPRX $68.77 $19.01 −72% vs STRAP

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend StocksUndervalued 52-Week Low StocksStocks for 2027: Large Companies Below Fair Value

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Free calculator Peter Lynch Fair Value Formula &…Free calculator
Run the numbers yourself: free valuation calculators
DCF CalculatorP/E Ratio CalculatorPEG Ratio CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorIntrinsic ValueIntrinsic vs Extrinsic ValueP/E Ratio by Sector
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Strategic Partners A/S does not have significant operations: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Strategic Partners A/S does not have significant operations Fair Value". https://www.fairvalue-calculator.com/stock/STRAP

Frequently asked questions

Is Strategic Partners A/S does not have significant operations (STRAP) overvalued or undervalued?
As of Nov 10, 2026, our estimate of fair value is kr 403.38 versus a price of kr 590.00, about 32% lower (overvalued).
What is the fair value of STRAP?
Our estimate for Strategic Partners A/S does not have significant operations is kr 403.38 (as of Nov 10, 2026), built from audited fundamentals. The current price: kr 590.00.
What is the quality score of STRAP?
Strategic Partners A/S does not have significant operations has a Quality Score of 49/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Strategic Partners A/S does not have significant operations (STRAP)?
Our calculated price target is the estimate of kr 403.38 (as of Nov 10, 2026). Cautious scenario kr 302.53, optimistic scenario kr 504.22. It is an estimate from revenue and assets compared with similar companies, because none of our valuation models currently carries, not an analyst target.
What is the Strategic Partners A/S does not have significant operations stock forecast for 2026?
Our estimate puts fair value at kr 403.38, about 32% lower versus a price of kr 590.00 (overvalued). Cautious scenario kr 302.53, optimistic scenario kr 504.22. The calculation is refreshed regularly with new filings.
What is the revenue of Strategic Partners A/S does not have significant operations (STRAP)?
Strategic Partners A/S does not have significant operations reported trailing-twelve-month revenue of about 304K DKK (latest available figure, as of Nov 10, 2026).
What is the intrinsic value of Strategic Partners A/S does not have significant operations (STRAP)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Strategic Partners A/S does not have significant operations it is kr 403.38 per share (as of Nov 10, 2026), against a price of kr 590.00.
Is Strategic Partners A/S does not have significant operations stock overvalued or undervalued in 2026?
As of Nov 10, 2026, STRAP trades above its calculated fair value: price kr 590.00, fair value kr 403.38, a gap of about −32% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of STRAP?
No. The price is what the market pays today (kr 590.00); the fair value is what the company's own numbers justify (kr 403.38). For Strategic Partners A/S does not have significant operations the two are kr 186.62 per share apart. That gap is exactly why we show both numbers side by side.
How much is Strategic Partners A/S does not have significant operations worth?
The market values Strategic Partners A/S does not have significant operations at about 32.7M DKK (market capitalisation, as of Nov 10, 2026). Per share that is kr 590.00; our models calculate a fair value of kr 403.38 per share.
What do the bullish and bearish scenarios say about STRAP?
Our models span a range for Strategic Partners A/S does not have significant operations: cautious scenario kr 302.53, base kr 403.38, optimistic kr 504.22 per share (as of Nov 10, 2026, price kr 590.00). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of STRAP?
Strategic Partners A/S does not have significant operations trades at a price-to-earnings ratio of 20.1 (as of Nov 10, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of kr 403.38 is built from several models across several years. Other multiples: P/B 1.8.
How solid is the balance sheet of Strategic Partners A/S does not have significant operations (STRAP)?
Balance-sheet figures for Strategic Partners A/S does not have significant operations (as of Nov 10, 2026): return on equity 7.2%. They feed the Quality Score of 49/100, which measures business quality independently of the share price.
How far is STRAP from its 52-week high?
Strategic Partners A/S does not have significant operations trades at kr 590.00, about 33% below its 52-week high of kr 880.00 and 11% above the low of kr 530.00 (as of Nov 9, 2026). Distance from the high says nothing about value: that is what the fair value of kr 403.38 is for.
Which stocks are comparable to Strategic Partners A/S does not have significant operations?
From the same area (Healthcare) we also value Vertex Pharmaceuticals Incorporated, Regeneron Pharmaceuticals, Inc, CSL Limited, argenx SE, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Strategic Partners A/S does not have significant operations stock attractive at the current price?
The data as of Nov 10, 2026: price kr 590.00, calculated fair value kr 403.38 (−32%), Quality Score 49/100. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
Is it still worth investing in stocks now?
The global stock market currently sits 13.7% above its aggregate fair value. Strategic Partners A/S does not have significant operations itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Strategic Partners A/S does not have significant operations (STRAP)?
The closing price on Nov 9, 2026 was kr 590.00. Our estimate is kr 403.38, about 32% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Strategic Partners A/S does not have significant operations right now?
The price sits above even our optimistic bull case (kr 504.22). The favourable scenario is already priced in. Weak quality (49/100) and above fair value at the same time, the margin of safety is missing on both counts. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.

Key figures of Strategic Partners A/S does not have significant operations

How large is the market capitalisation of Strategic Partners A/S does not have significant operations (STRAP)?
The market capitalisation of Strategic Partners A/S does not have significant operations is 32.7M DKK (≈ $4.9M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What are the earnings per share of Strategic Partners A/S does not have significant operations (STRAP)?
Earnings per share at Strategic Partners A/S does not have significant operations are kr 29.33 (price ÷ EPS = P/E 20.1). Earnings per share over the last twelve months: total profit spread across every single share.
What is the return on equity of Strategic Partners A/S does not have significant operations (STRAP)?
The return on equity (ROE) of Strategic Partners A/S does not have significant operations is 7.2% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Strategic Partners A/S does not have significant operations (STRAP)?
On an EBIT basis the return on assets of Strategic Partners A/S does not have significant operations is −54.8% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Strategic Partners A/S does not have significant operations (STRAP)?
The operating margin of Strategic Partners A/S does not have significant operations is −927% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Strategic Partners A/S does not have significant operations (STRAP)?
Revenue at Strategic Partners A/S does not have significant operations is growing −4.8% versus a year earlier (3y avg −79.6%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does Strategic Partners A/S does not have significant operations (STRAP) generate?
The free cash flow of Strategic Partners A/S does not have significant operations is −2.1M DKK (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net cash does Strategic Partners A/S does not have significant operations (STRAP) hold?
Strategic Partners A/S does not have significant operations holds more cash than debt, 394K DKK net (fiscal year 2025). The company holds more cash than debt, a safety cushion.
Free · no account needed

Watch Strategic Partners A/S does not have significant operations in the live analysis

One click puts Strategic Partners A/S does not have significant operations on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.